[
    [
        {
            "time": "",
            "original_text": "【健帆生物|预告点评】20年Q1业绩大幅超预期，行业认可度与渗透率不断提升【安信医药马帅团队】",
            "features": {
                "keywords": [
                    "健帆生物",
                    "20年Q1",
                    "业绩",
                    "超预期",
                    "行业认可度",
                    "渗透率"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【健帆生物|预告点评】20年Q1业绩大幅超预期，行业认可度与渗透率不断提升【安信医药马帅团队】",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "A股异动 | 健帆生物涨逾6% 料一季度净利同比增30%至50%",
            "features": {
                "keywords": [
                    "A股",
                    "健帆生物",
                    "涨逾6%",
                    "一季度",
                    "净利",
                    "同比增30%至50%"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股异动 | 健帆生物涨逾6% 料一季度净利同比增30%至50%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]